Centogene NV(NASDAQ : CNTG)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Commercial Services » Miscellaneous Commercial Services
|FLT||FLEETCOR Technologies, Inc.||0.09%||208.06||3.7%||$147.05m|
|CRL||Charles River Laboratories International, Inc.||-2.32%||357.47||4.5%||$142.89m|
|ADGI||Adagio Therapeutics, Inc.||-1.42%||45.83||0.0%||$128.26m|
|FOUR||Shift4 Payments, Inc.||-2.84%||51.00||0.0%||$95.59m|
|TAL||TAL Education Group||-8.98%||4.56||0.7%||$89.42m|
|BKKT||Bakkt Holdings, Inc.||-6.66%||13.03||0.0%||$88.61m|
|MRVI||Maravai Lifesciences Holdings, Inc.||-2.05%||42.15||0.0%||$82.19m|
|PAGS||PagSeguro Digital Ltd.||-5.78%||24.80||0.0%||$77.20m|
|SYNH||Syneos Health, Inc.||-1.44%||97.23||0.0%||$70.18m|
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.